Rectal cancer breakthrough: Watch-and-Wait may spare patients from surgery
NCT ID NCT07260526
First seen Jan 09, 2026 · Last updated May 08, 2026 · Updated 15 times
Summary
This study is for people with early- or intermediate-risk low rectal cancer. It tests whether patients who respond well to chemotherapy and radiation can safely avoid surgery and instead be closely monitored (watch-and-wait). The goal is to preserve the rectum and improve quality of life without compromising cancer control. About 60 participants will be followed for one year to see how many can avoid major surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.